Owl monkey genomic DNA prepared from OMK cells and a sample of whole blood (Aotus trivirgatus, cryopreserved since 1994) was purified by using Qiagen kits. A genomic DNA clone containing the 3Ј end of Trim5 exon 7, the 5Ј end of exon 8, and intervening sequences was obtained by PCR using F3gen (CCGACAGAAGTCCAACGCTACTGG) and R3gen (TGA-CAGTACATGAAGGGTGACTTGG) primers and KOD HiFi polymerase (Novagen) (30 cycles; 15 sec at 95°C, 30 sec at 62°C, and 30 sec at 72°C). Other genomic PCRs used F3gen with CypA-R (ACCCAAAGCGCTCCATGG-CCTCCAC) and CypA-F5 (GAGAACTTCATCCTAAAGCATACAGG) with R3gen. Sequences have been deposited in GenBank.
GST Pull-Down. The CA protein of HIV-1 was PCR-amplified by using pNL4.3 with primers CA-F (GGGAATTCATGCCTAT-AGTGCAGAACCTCCAGGGG) and CA-R (GGCTCGAGT-CACAAAACTCTTGCTTTATGGGCCGGG) and cloned into pGEX6P1 (Amersham Biosciences, Chalfont St. Giles, U.K.) between the EcoRI and XhoI restriction sites to generate a GST-CA fusion. The resulting plasmid was introduced into competent BL21(DE3) Escherichia coli (One Shot, Invitrogen). Two-hundred-milliliter cultures were induced for 3 h with 1 mM isopropyl ␤-D-thiogalactoside, and cell extracts were prepared by resuspending cell pellets in 5 ml of Yeast Protein Extraction Reagent (Pierce), 5 mM MgCl 2, and 125 units of Benzonase nuclease (Novagen), and incubating for 5 min at room temperature and 30 min on a spinning wheel at 4°C, followed by centrifugation at 30,000 ϫ g for 30 min. Trim-V2, -V4, and -V6 were subcloned into pEXP2-DEST Gateway (Invitrogen) from the pENTR constructs by recombination using Gateway LR Clonase (Invitrogen). Two micrograms of plasmid DNA was used for in vitro transcription͞translation with the TNT coupled reticulocyte lysate system (Promega) labeling the protein product with Redivue L-[ One milliliter of glutathione Sepharose 4B beads (Amersham Biosciences) was incubated overnight at 4°C with 500 l of crude bacterial extract (corresponding to Ϸ500 g of GST-CA). The beads were washed three times with 10 ml of GST pull-down buffer (20 mM Tris, pH 8.0͞100 mM NaCl͞5 mM MgCl 2 ͞0.5% Nonidet P-40͞5% glycerol͞1 mM EDTA͞10 g/ml BSA). Fifteen microliters of in vitro-translated TRIM5-V2, -V4, or -V6 was incubated with 50 l of beads in a final volume of 1.5 ml of GST pull-down buffer for 1 h at 4°C. Beads were then washed five times in GST pull-down buffer and resuspended in 30 l of SDS͞PAGE loading buffer for 10 min at 95°C. Eluates were run on a 10% polyacrylamide gel. Before autoradiography, overnight at Ϫ80°C, gels were incubated for 30 min in 50% methanol͞10% acetic acid, for 30 min in Amplify reagent (Amersham Biosciences), and for 5 min in 7% methanol͞7% acetic acid͞1% glycerol, and dried for 1 h at 80°C.
Results

Presence of a CypA Pseudogene in the Owl Monkey Trim5 Locus.
There is now good evidence that the Trim5 gene encodes Lv1 activity in a variety of Old World monkeys (22) (23) (24) (25) . However, the OMK restriction factor shows a unique pattern of HIV-1 restriction. It does not affect HIV-1 modified to prevent CypA binding, and restriction is abolished by the treatment of cells with CsA (21) . We therefore asked whether Trim5 was also responsible for the restriction activity of OMK cells. Our previous attempts to clone the OMK Trim5 gene by using RT-PCR were unsuccessful (25) . Therefore, we used a variant of the 3Ј RACE technique for this purpose. Products from this reaction were cloned and sequenced. Among the first clones screened, we identified one product showing a fusion between Trim5 and CypA sequences (Trim5-V1; see below).
Using the cDNA sequence, we designed primers to OMK DNA corresponding to exons 7 and 8 of the human Trim5␣ locus. PCRs with genomic DNA isolated from OMK cells and from a sample of A. trivirgatus blood revealed a single product of 1.1 kb (Fig. 1) , Ϸ0.55 kb longer than the predicted corresponding product with human DNA. Reactions with the exon 7 primer plus a CypA reverse primer, and a CypA forward primer with the exon 8 primer both gave bands of about 0.6 kb. Sequencing of the 1.1-kb product revealed the presence of an intact CypA ORF (Fig. 2) . This ORF has all of the hallmarks of a processed pseudogene (29) . An intact, intronless CypA ORF is followed by a 3Ј untranslated region with a short A-rich sequence located 18 nt after a potential polyadenylation signal. The CypA sequences are flanked by a 15-nt duplication that appears only once in the corresponding human Trim5 intron. Potential splice-acceptor and splice-donor sequences were also identified within the pseudogene. Together, these observations suggested the possibility of a Trim5-CypA fusion protein that might provide an elegant explanation for the unique CypA dependence of HIV-1 restriction in OMK cells.
Analysis of Trim5-CypA Fusion Transcripts. The first Trim5-CypA mRNA cloned, Trim5-V1 (Fig. 3) would not be predicted to yield an in-frame fusion protein because of the absence of Trim5 exon 6. We therefore screened our collection of RACE products further. This screen led to the identification of two further variants, Trim5-V2 and -V3. V2 would be predicted to yield a fusion protein containing amino acids 1-299 of Trim5␣, followed by 11 aa derived from the 5Ј untranslated region of CypA plus amino acids 1-147 of CypA. However, it lacks the last 17 aa of CypA; these are replaced by 16 aa derived from exon 8 of Trim5 but in a different reading frame. V3 has exons 1-5 of Trim5, exon 7 read in a different frame, five nucleotides of unknown origin, followed by the Trim5 exon 8.
To clone a variant containing all of the CypA coding sequences, we used RT-PCR with primers directed to the 5Ј end of Trim5 and the 3Ј end of the CypA ORF. Two products, Trim-V4 and -V5, were obtained in this way. V4 would be predicted to yield a fusion protein analogous to V2 but with the CypA C-terminal residues. A comparison of the predicted amino acid sequences of proteins encoded by Trim-V4 and -V2 is shown in Fig. 4 . V5 is an incompletely spliced version of V4. Whether other spliced variants are made in vivo is not clear. One possibility is that the CypA sequences are removed by normal splicing between exons 7 and 8 of the Trim5 gene. We have been unable to detect such a product, but for further functional analyses, we generated such a cDNA in vitro, Trim5-V6, by PCR-mediated deletion of CypA-derived sequences from Trim5-V2.
Trim5-CypA Restriction of HIV-1. We next set out to examine the restriction properties of the various cloned Trim5 cDNAs from OMK cells. For comparison, the patterns of natural restriction in OMK cells were also examined. Virus titration on human 293T and OMK cells showed that HIV-1 is significantly restricted in OMK, compared with human cells, an inhibitory effect that can be overcome by introduction of the G89V mutation (Fig. 5A) . CsA treatment shows slight inhibition of HIV-1 on human cells but abolishes restriction in OMK cells (Fig. 5B) . CsA has little effect on the virus with G89V. These results confirm those of earlier reports (13, 21) .
To test the cloned cDNAs, we used a two-color FACS assay originally developed for the study of Fv1 (26, 27) and adapted for HIV-1 (25) . Human HT1080 cells were transduced with an MLV-based vector encoding the gene to be examined and yellow fluorescent protein, then challenged with tester viruses encoding enhanced GFP. The effect of the introduced gene can be assessed by comparing the proportion of GFP positive cells in the cell populations with and without yellow fluorescence.
The introduction of Trim5-V4, the variant carrying exons 1-7 of Trim5 fused to the intact CypA ORF, into human HT1080 cells resulted in the inhibition of both low and high doses of Below are the deduced structures of five naturally occurring spliced processed RNAs (V1-V5) and one potential transcript generated by recombinant techniques (V6). In frame, predicted translation in the normal Trim5 or CypA reading frame; Out of frame, use of an alternative frame. HIV-1 tester virus (Fig. 5 C and D) . No restriction was seen of G89V or of wild-type HIV-1 in the presence of CsA. Trim5-V4 expression thereby recapitulates the restriction properties of Lv1 in OMK cells. By contrast, Trim5-V2, which differs only in the very C-terminal region of the predicted protein, showed no effect on HIV-1 replication (data not shown). Interestingly, Trim5-V6, the equivalent of the Trim5␣ gene present in other species of primate, also showed no restriction activity against either HIV-1 or MLV (data not shown), presumably as a result of sequence divergence.
Trim5-CypA Interaction with CA. CypA binds to HIV-1 CA protein (16) . To test whether the Trim5-CypA fusion proteins encoded by Trim5-V2 and -V4 were also capable of binding HIV-1 CA, we incubated GST-tagged CA with in vitro-synthesized 35 Slabeled Trim5-CypA and tested for binding to glutathionecoated beads. Fig. 6 illustrates the result on one such experiment. Restriction-competent Trim5-V4 binds CA; binding is abolished by CsA addition. By contrast, Trim5-V2, which does not restrict HIV-1, showed no CA binding. Trim5-V6, equivalent to intact OMK Trim5␣, also showed no CA binding.
Discussion
In this study, we show that a processed CypA pseudogene is present within the Trim5 locus of OMK cells and provide evidence that a chimeric Trim5-CypA protein is responsible for Lv1 restriction in OMK cells. Recently, others have reported similar findings (30) . As is the case in OMK cells, Trim5-CypAmediated restriction appears dependent on a CypA-CA interaction. An alternatively processed variant, encoded by Trim5-V2, which differs only at the extreme C terminus of the predicted protein, neither binds CA nor restricts HIV-1. The structure of CypA provides a plausible explanation for this finding; CypA appears to show an eight-stranded antiparallel ␤-barrel structure (31) . Changes in the final ␤-sheet are therefore likely to disrupt the whole structure. The observed lack of restriction activity in Trim5-V6-transduced cells implies that even if full-length Trim5␣ protein is made in OMK cells, it does not contribute to HIV-1 restriction. In addition, siRNA to Trim5 has been reported to inhibit HIV-1 replication in OMK cells (23, 30) . Taken together, these observations imply that Trim5-CypA is the primary factor responsible for HIV-1 restriction in OMK cells.
Intact Trim5␣ appears to be constructed in a modular fashion with the domains comprising the tripartite motif followed by a SPRY domain (32) . In the Trim5-CypA chimera, the CypA residues almost precisely replace the SPRY domain. Restriction specificity of Trim5␣ from human, rhesus and African green monkey for HIV-1 and MLV maps to the SPRY domain (M.W.Y., S.N., and J.P.S., unpublished work). It therefore seems likely that the CypA insertion results in the exchange of one virus-binding domain with another. The Trim5-CypA fusion protein might therefore be valuable for studying the role in restriction of the remaining portion of the Trim protein, not least by providing an ideal unrestricted control, G89V, in studies designed to follow incoming virus.
The inserted CypA sequences present within intron 7 of the OMK Trim5 gene appear to represent a typical processed pseudogene, lacking introns but containing a 3Ј poly(A) tract and generating a duplication in insertion site sequence (29) . This pseudogene presumably resulted from L1-mediated retransposition of an authentic CypA transcript (33) . This insertion does not appear to have occurred during the growth on OMK cells in culture because the pseudogene was also present in genomic DNA from a sample of frozen whole blood taken from an owl monkey. Both OMK cells and blood came from members of the A. trivirgatus species; it will be of interest to examine the distribution of the Trim5-CypA gene in more members of the Aotus genus from different geographic locations.
Owl monkeys are normally found in Central and South America. It therefore seems unlikely that they would have been exposed to primate lentiviruses, and it is unclear whether any selective advantage might be conferred by acquisition of the hybrid gene. However, even though CypA is a very common pseudogene (34) , it seems improbable that the chimeric ORF would be maintained without selection unless it is a very recent insertion.
Over the course of evolution, mammals have accumulated tens of thousands of pseudogenes (34, 35) . Although the process of retrotransposition may have been necessary for genome evolution (36), the vast majority of existing pseudogenes are considered as ''junk'' DNA. Although some are transcribed, many have accumulated mutations that would preclude function, and only a very small number may play physiological roles (37) (38) (39) . Indeed, even though exon shuffling may have been of great importance in the evolutionary past (40, 41) , the Trim5-CypA protein appears to belong to a tiny handful of functional proteins unambiguously created in this manner.
